ArticleBritish journal of cancer2017

Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy.

Amir Faisal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.